Journal Home
Search for

Volume 582, Issue 12, Pages 1719-1724 (28 May 2008)


View previous. 16 of 26 View next.

High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-κB activation in vascular endothelial cells

Edited by Laszlo Nagy

Yoshiyuki HattoriaCorresponding Author Informationemail address, Yasuko Nakanob, Sachiko Hattoria, Atsuko Tomizawaa, Kouichi Inukaic, Kiuo Kasaia

Received 11 January 2008; received in revised form 14 April 2008; accepted 18 April 2008. published online 01 May 2008.

Abstract 

Various isoforms of adiponectin circulate in the plasma. We purified high molecular weight (HMW) adiponectin from human plasma. HMW adiponectin was observed to activate AMP-activated protein kinase (AMPK), thereby increasing the phosphorylation of eNOS and NO production in endothelial cells. On the other hand, cells preincubated with HMW adiponectin had reduced TNFα-induced NF-κB activation. HMW adiponectin by itself was found to modestly activate NF-κB, which was significantly enhanced by inhibition of AMPK/eNOS activation. Thus, HMW adiponectin might have dual action, both pro and anti-inflammatory. An initial period of NF-κB activation by HMW adiponectin might be proinflammatory, but it could be counteracted by activation of AMPK/eNOS, which lead to a potential reduction in a second activation of NF-κB against inflammatory stimuli.

a Department of Endocrinology and Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi, Japan

b Department of Medicinal Information, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan

c Division of Endocrinology and Diabetes, Department of Medicine, Saitama Medical University, Saitama, Japan

Corresponding Author InformationCorresponding author. Fax: +81 282 86 4632.

PII: S0014-5793(08)00367-0

doi:10.1016/j.febslet.2008.04.037


View previous. 16 of 26 View next.